N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2

J Med Chem. 2014 Aug 14;57(15):6873-8. doi: 10.1021/jm500722p. Epub 2014 Jul 23.

Abstract

New analogues (UPam) of triacylated lipopeptide Pam3CysSK4, a popular agonist of Toll-like receptor 2 (TLR2), were designed making use of the cocrystal structure of a TLR2 heterodimer (with TLR1) with Pam3CysSK4. Twenty-two UPam derivatives that feature an N-tetradecylcarbamyl chain to mimic the native N-palmitoyl moiety and various small amino acids residues at the penultimate N-terminal position were prepared via solid-phase synthesis. In vitro evaluation of immunostimulatory properties revealed new potent TLR2 ligands.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / chemical synthesis
  • Adjuvants, Immunologic / chemistry*
  • Adjuvants, Immunologic / pharmacology
  • Carbamates / chemical synthesis
  • Carbamates / chemistry*
  • Carbamates / pharmacology
  • Cell Line
  • Crystallography, X-Ray
  • Dendritic Cells / drug effects
  • Dendritic Cells / physiology
  • Humans
  • Lipopeptides / chemical synthesis
  • Lipopeptides / chemistry*
  • Lipopeptides / pharmacology
  • Molecular Structure
  • Structure-Activity Relationship
  • Toll-Like Receptor 1 / chemistry
  • Toll-Like Receptor 2 / agonists*
  • Toll-Like Receptor 2 / chemistry

Substances

  • Adjuvants, Immunologic
  • Carbamates
  • Lipopeptides
  • Pam(3)CSK(4) peptide
  • Toll-Like Receptor 1
  • Toll-Like Receptor 2